Renée A. Douma1; Nadine S. Gibson1; Victor E. A. Gerdes1,2; Harry R. Büller1; Philip S. Wells3; Arnaud Perrier4; Grégoire Le Gal5
1Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands; 2Department of Internal Medicine, Slotervaartziekenhuis, Amsterdam, the Netherlands; 3Department of Medicine, University of Ottawa, Ottawa Hospital & Ottawa Health Research Institute, Ottawa, Ontario, Canada; 4Division of Internal General Medicine, Geneva University Hospital, Geneva, Switzerland; 5Department of Internal Medicine and Chest Diseases, CHU la Cavale Blanche, Brest, France
Diagnosis, pulmonary embolism, D-dimer, clinical decision rule, Wells rule
The recently introduced simplified Wells rule for the exclusion of pulmonary embolism (PE) assigns only one point to the seven variables of the original Wells rule. This study was performed to independently validate the simplified Wells rule for the exclusion of PE. We retrospectively calculated the prevalence of PE in the "unlikely" probability categories of the original Wells (cut-off ≤4) and the simplified Wells rule (cut-off ≤1) in 922 consecutive patients with clinically suspected PE from a multicenter cohort study. We compared the three-month incidence of venous thromboembolism (VTE) in patients with an unlikely probability and a normal D-dimer test using both scores, and the proportion of patients with this combination (clinical utility). The proportion of patients categorized as PE "unlikely" was similar using the original (78%) and the simplified (70%) Wells rule. The prevalence of PE was 13% (95% confidence interval [CI], 11–16%) and 12% (95%CI, 9.7–15%) for the original Wells and simplified Wells "unlikely" categories, respectively. None of the patients with PE "unlikely" and a normal D-dimer test experienced VTE during three-month follow-up. The proportions of patients in whom further tests could safely be withheld based on PE "unlikely" and a normal D-dimer test was 28% (95%CI, 25–31%) using the original and 26% (95%CI, 24–29%) using the simplified Wells rule. In this external retrospective validation study, the simplified Wells rule appeared to be safe and clinically useful, although prospective validation remains necessary. Simplification of the Wells rule may enhance the applicability.
Robbert J. Goekoop1, Neeltje Steeghs1, Rene W. L. M. Niessen2, Gé J. P. M. Jonkers3, Hans Dik4,Ad Castel5, Lies Werker-van Gelder6, L. Tom Vlasveld6, Rik C. J. van Klink7, Erwin V. Planken8, Menno V. Huisman1
Thromb Haemost 2007 97 1: 146-150
Marc Righini1 , Grégoire Le Gal3 , Sylvain De Lucia2 , Pierre-Marie Roy 5 , Guy Meyer 4 , Drahomir Aujesky6 , Henri Bounameaux1 , Arnaud Perrier2
Thromb Haemost 2006 95 4: 715-719
Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients
Explanations and potential ameliorations
R. A. Douma (1), G. L. van Sluis (1), P. W. Kamphuisen (1), M. Söhne (1), F. W. G. Leebeek (2), P. M. M. Bossuyt (3), H. R. Büller (1)
Thromb Haemost 2010 104 4: 831-836
The article “Feasibility and cost effectiveness of stroke prevention through community screening...
The April 2014 TH 111.4 issue of Thrombosis and Haemostasis is a Theme Issue by Guest Editor B....
Women with atrial fibrillation have a much higher risk for thromboembolic stroke than men suffering...